Kieran F Docherty Selected Research

Kieran F Docherty Research Topics

Disease

91	Heart Failure 05/2024 - 06/2016
10	Type 2 Diabetes Mellitus (MODY) 05/2024 - 10/2019
9	Cardiomyopathies (Cardiomyopathy) 05/2024 - 01/2020
9	Myocardial Infarction 05/2024 - 06/2016
7	Atrial Fibrillation 01/2023 - 01/2018
6	Left Ventricular Dysfunction 05/2024 - 06/2016
4	Stroke (Strokes) 03/2024 - 06/2016
4	Chronic Renal Insufficiency 11/2023 - 01/2022
3	Sudden Death 01/2022 - 01/2019
3	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2021
2	Iron Deficiencies 03/2024 - 01/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 01/2021
2	Fatigue 11/2023 - 01/2022
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2023 - 10/2019
2	Gout 01/2023 - 01/2022
2	Prediabetic State (Prediabetes) 01/2022 - 01/2021
2	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2019
1	Ventricular Dysfunction 04/2024
1	Transient Ischemic Attack 03/2024
1	Alzheimer Disease (Alzheimer's Disease) 12/2023
1	Renal Insufficiency (Renal Failure) 11/2023
1	Anemia 01/2023
1	Infarction (Infarctions) 01/2023
1	Infections 01/2023
1	Hyperuricemia 01/2023
1	Peripheral Arterial Disease 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	COVID-19 01/2022
1	Shock 01/2022
1	Hyponatremia 01/2022
1	Frailty 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Ventricular Remodeling 01/2021
1	Ischemic Stroke 01/2021
1	Diabetes Mellitus 01/2021

Drug/Important Bio-Agent (IBA)

49	dapagliflozinIBA 05/2024 - 11/2019
16	Sodium-Glucose Transport ProteinsIBA 05/2024 - 11/2019
10	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 11/2019
10	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 04/2019
9	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2024 - 11/2019
9	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 01/2021
9	SodiumIBA 11/2023 - 01/2020
9	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2023 - 04/2019
6	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 04/2019
6	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 01/2021
6	DiureticsIBA 11/2023 - 01/2020
6	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 11/2018
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2021
5	Natriuretic PeptidesIBA 12/2023 - 01/2020
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 06/2016
4	CreatinineIBA 03/2024 - 10/2019
4	SymportersIBA 11/2023 - 01/2021
4	omecamtiv mecarbilIBA 09/2023 - 01/2022
4	Enalapril FDA LinkGeneric 01/2023 - 04/2019
3	empagliflozinIBA 05/2024 - 01/2021
3	Angiotensin Receptor AntagonistsIBA 01/2022 - 06/2016
3	Valsartan (Vals)FDA Link 01/2021 - 06/2016
2	IronIBA 03/2024 - 01/2022
2	Ferritins (Ferritin)IBA 03/2024 - 01/2022
2	Transferrin (beta 2 Transferrin)IBA 03/2024 - 01/2022
2	Irbesartan FDA LinkGeneric 03/2024 - 01/2019
2	Furosemide (Lasix)FDA LinkGeneric 10/2023 - 01/2023
2	Uric Acid (Urate)IBA 01/2023 - 01/2022
2	Cardiac MyosinsIBA 01/2023 - 01/2022
2	Troponin T (Troponin T1)IBA 01/2022 - 04/2020
2	SugarsIBA 01/2022 - 01/2021
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 10/2019
1	ferric derisomaltoseIBA 03/2024
1	paragonIBA 03/2024
1	A-factor (Streptomyces)IBA 01/2024
1	CarbohydratesIBA 11/2023
1	AntigensIBA 11/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2023
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023
1	Colchicine FDA LinkGeneric 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Metolazone (Diulo)FDA LinkGeneric 01/2023
1	CanagliflozinIBA 01/2023
1	Endothelin-1 (Endothelin 1)IBA 01/2023
1	insulin-like growth factor binding protein-related protein 1IBA 01/2023
1	ThiazidesIBA 01/2023
1	AldosteroneIBA 06/2022
1	TroponinIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Erythropoietin FDA Link 01/2022
1	HepcidinsIBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022

Therapy/Procedure

30	Therapeutics 05/2024 - 02/2013
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 01/2021
2	Cardiac Resynchronization Therapy 01/2022 - 01/2021
1	Percutaneous Coronary Intervention 04/2024
1	Infusion Pumps (Infusion Pump) 10/2023
1	Surgical Amputation (Amputations) 01/2023
1	Ambulatory Care (Outpatient Care) 01/2023
1	Secondary Prevention 01/2023
1	Defibrillators (Defibrillator) 01/2022